巨噬细胞不仅可以启动、调节免疫应答，也可作为最终的效应细胞。
Macrophages not only initiate and modulate immune responses, but also are the final effector cells.
而改进治疗方式或实施联合治疗，将有可能延长、放大或调节这类免疫应答，并提高癌症抗体治疗的临床效果。
Future treatment modifications or combinations might be able to prolong, amplify, and shape these immune responses to increase the clinical benefits of antibody therapy for human cancer.
NKT细胞在抗肿瘤免疫、 获得性免疫应答及免疫调节中起着重要作用。
NKT cells play an important role in anti-tumor immunity, adaptive immune responses and immunoregulation.
应用推荐